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The primary structure of bovine cathepsin S was determined by combining results of protein and peptide sequencing with the sequence deduced 
from nucleic acid sequencing. Using polymerase chain reaction (J-CR) technology, cDNA clones commencing at amino acid 22 of the mature en- 
zyme and continuing through the 3’ untranslated region of bovine cathepsin S mRNA were isolated and sequenced. The open reading frame in 
these overlapping clones correctly predicts the determined amino acid sequence of 13 tryptic peptides derived from purified bovine spleen cathepsin 
S. The deduced amino acid sequence shows that mature bovine cathepsin S consists of 217 amino acids corresponding to a molecular weight of 
23.7 kDa. Cathepsin S belongs to the papain superfamily of lysosomal cysteine proteinases and shares 41% identity with papain. Amino acid se- 
quence identities of bovine cathepsin S to human cathepsins L, H, and I3 are 56%, 47% and 31% respectively. 
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1. INTRODUCTION 
Lysosomal cysteine proteinases are important for 
cellular protein breakdown. The cathepsins B (EC 
3.4.22.1), H (EC 3.4.22.16) and L (EC 3.42215) are 
the best characterized enzymes of this group [l]. The 
recently described cathepsin S [2,3] has a high specific 
activity towards protein substrates, a property it shares 
with cathepsin L. However, cathepsin S differs from 
cathepsin L since it is a single chain enzyme like papain. 
Furthermore, it differs from all cysteine proteinases 
since it is stable and active in vitro at neutral pH. 
The N-terminal part (35 amino acid residues) of the 
bovine cathepsin Ssequence was reported by Turk et al. 
[4] as that of bovine cathepsin L. At that time, cathep- 
sin S was insufficiently characterized, and therefore, 
the enzyme isoIated from bovine spIeen was thought to 
be a species variant of cathepsin L. We report here the 
primary structure of bovine cathepsin S. This informa- 
tion is necessary for the ultimate determination of the 
structural basis for the difference in properties of the 
cathepsins. We have compared the amino acid sequence 
of the cathepsins in the region of cleavage of cathepsins 
L and H into heavy and light chains and propose an ex- 
planation based on secondary structure for the failure 
of cathepsin S to be similarly cleaved in this region. 
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2. MATERIALS AND METHODS 
2.1. Purification alkylation, and try&n digestion of cathepsin S 
Cathepsin S was purified from bovine spleen as described previous- 
ly [3]. The purified protein (25pg) was alkylated with 4-vinylpyridine 
[S] and desalted by reversed phase chromatography on a 0.46 x 3 cm 
TSK TMS250 (Cl) column. Alkylated cathepsin S was dissolved in 60 
ul 0.1 M ammouium bicarbonate and treated with 4% (w/w) TPCK- 
trypsin (Sigma) for 8 h. Tryptic peptides were separated by reversed 
phase chromatography on a 0.46 x 15 cm Vydac 218TPI35 column us- 
ing a linear gradient of acetonitrile (O-60070 in 90 min) in 0.1% 
trifluoroacetic acid. 
2.2. Amino acid sequencing 
Unalkylated cathepsin S as well as the trypticpeptides were degrad- 
ed (Applied Biosystems program 03RPTH) in a gas/pulsed liquid se- 
quencer [6] connected to an on-line PTH-amino acid analyzer con- 
sisting of a Brownlee MicroGradient syringe pump, Rheodyne 7126 
pneumatic injector, Jones chromatography oven and a Spectra 
Physics SP 8450 detector. PTH-amino acids were separated on an 
Applied Biosystems PTH C-18 column using conditions described for 
the Applied Biosystems 120A PTH-analyzer. For degradation, 
samples were applied on Polybrene (2 mg) pretreated glass fiber discs. 
2.3. cDNA cloning 
RNA was purified from bovine spleen 171 and mRNA was isolated 
[S]. mRNA (0.5& was reverse transcribed by avian myelob;astosis 
virus reverse transcriptase (Bethesda Research Laboratories) using 
oligo-(dT)l2-18 or oligo-(dT)-adapter as primer according to the 
manufacturers recommendations. Amplification of cathepsin S 
cDNA by polymerase chain reaction (PCR) was essentially according 
IO Frohman et al, [9], Reactions were amplified for 25 cycles. The 
PCR cycle used was I ’ -3 ‘-I ’ at SJ°C, 6S”C, attd 94”C, respectively. 
Oligo nucleotide primers arc listed in Fig, I. 
After chloroform extraction and ethanol prccipltation PCR 
products were treated with DNA polymeraac I Klenow fragment 
(Bethesda Research Labs) to ensure the ettds were flush. Agarose gel 
purified cDNAs were directly cloned into the S~tral site of 
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Primers Used to Clsne Bovine Cathepsin S Bovine Cathepsin S cDPdi4 
Primen 
--+*----4i- 
Sequatlced - 
negions 4 
ILPDSMDWKEKGCVTEVKYQG 
-- 
Fig. 1. ‘Indicates primers which are antisense. Primers l-4 were 
chosen from the possible codons for the corresponding peptide se- 
quences. Wobble bases were included in these primers towards the 3’ 
end to ensure efficient replication by Taq polymerase (N = C,A,T,C; 
U = G,A; Y = C,T). The sequences of primers 5.6, and 7 were taken 
from the nucleic acid sequence of the first cathepsin S clones isolated. 
TCTCCCTClTCCTCGGCTTTCAGTG~GTGGGAGCCAG 57 
21AC G SC W A F S AV G ALE AQ V K L 
AAAACAGGAAAG~GGTGGAGTGCACAACCTCAAAA 117 
blK T G K L V S L S A 0 N L V DCS T A K 
TATGGGAATAAAGG~GCAATGGCGG~ATGACAGAGG~CCAATATATCA~GAC 177 
61Y G N KG C N G G FM T EA FQY I I D 
AACAATCCCATCGAlTCAGAAG~C~ATCC~ACAAA~CATGGATGGAAAGTGCCAG 237 
SIN N G I D S E A S Y P Y K A M DG K C_g 
pGem-7Zf( c ) (Promega Biotec) by blunt-end ligation using T4 ligase 
(Bethesda Research Labs) according to the manufacturers instruc- 
tions. 
TATTCATGTAAAAAATCGAGCCACGTGTTCAAGGTATATi-GAACXTCCClTCGGCAGC 297 
lO1Y D V K N R A A TCS R Y I EL P FG S 
GAACAGGCCITAAAAGAAGCCGTGGCCAATAAAGGACCICGCG 357 
I21E E A L K E A V AN K G P V S V G I DA 
2.4. DNA sequencing 
AGCCA'I1'XRXTCCT-TCCTCTACAAAACfGGTGTCTACTATGACCCC%XCACTCAG 417 
161s H S S F F L Y K TG V Y Y D PS C T9 
Plasmid DNA was isolated by the alkaline lysis procedure [IO] 
followed by polyethylene glycol precipitation. Double stranded DNA 
AATGTCAACCATGGTGTACTGG~GGCTATGGTAAC~GACGGGAAGGA~A~GC 177 
161fl N H G V L V V C Y G N L DG K D Y W 
was sequenced by the dideoxy chain termination method using the T7 
DNA polymerase enzyme, Sequenase (US Biochemical@ according to 
(IITGTGAAAAACAC~GCGGC~GCA~GGTGACCAAGGATATATACGGATGGCAAGA 537 
the manufacturers specifications. 
181 LV K N S W C L H FG DQGYIR MI\R 
* 
2.S. Estimation of size of cathepsin S mRNA 
Glyoxylated RNA samples [II] were electrophoresed in 25 mM 
sodium phoshate buffer, pH 6.S,2% Nusieve agarose, 0.1% Seakem 
agarose for 320 V. h at 4°C with buffer recirculation. The RNA was 
transferred to Nytran membrane (Schleicher and Schuell) according 
to the manufacturers instructions. Cathepsin § cDNA amplified with 
primer pair 1 and 2 was gel purified and 50 ng were labeled with 
dCT32P by random prime labelling 1121. Hybridization and washing 
conditions have been described 1131. 
TCTPTG'~?TTATAACAATTCAAGAAAAAAGAACCACTTTC~XACAATITAATTITACCTG 657 
~CTAACAGTAGAAATAAGTGTGATATGA~AATATATA~A~GTA~AACAGAAAAT 7i7 
ATACl'RGATlCATCTA ~AGC~GCAGAT~TGGGGAAAACITTCCTAAGTA 777 
* 
AA~AATAATGTACAATAGA~ATAACCCTATGAAAG~AG~A~GACACCAT~GTCA 037 
TC~~TATCAGTCI'CTTA~TTCTCCITTTAAGCUCCCTA~TATGCTGGTGAAACTTGATG 897 
GCATATACATGCTTAATAATATGATC1TITCAACGTATCA~ACCACATAC~ACCA 957 
'I'ICI'CI'L'l'l'~l'I'CI'IIhGTnh'PCATTC 1017 
TCGTGATCTCCTATGGCAA~ATCGAACAAACTAl'TAGGTTA'tTAATC~~GACAl-T 1077 
3. RESULTS AND DISCUSSION 
For direct primary structure analysis cathepsin S was 
purified from bovine spleen as described [3]. The 
purified enzyme (2yg) was subjected to 24 cycles in the 
sequencer. The determined sequence of the first 24 
amino acid residues (Fig, 2) shows three differences 
from the previously published one [4]; Met instead of 
Vat in position 5, Cys instead of Gly in position 12 and 
Glu instead of Pro in position 15. These differences are 
also confirmed by the sequenced tryptic peptides 
cathepsin S-(1-8).peptide and cathepsin S-(11-17)- 
peptide. The sequences of the purified tryptic peptides 
derived from alkylated cathepsin S are also shown in 
Fig. 2. 
Fig. 2. The heavy line in the map corresponds to the amino acid 
coding region. The lengths of cDNA clones isolated and the primers 
used are indicated. The solid arrows show the length and direction se- 
quenced using the SP6 and T7 primer sites in the plasmid. The first 
20nucleotides are the sequence of primer no.1 and not necessarily the 
sequence found in the bovine cathepsin S gene. The result from the N- 
terminal sequence analysis of the purified enzyme as well as results 
from sequence analyses of purified tryptic peptides are underlined. 
CTATCI1TCC\CATAAAACGA~CAATAAATA~AAAATCAGTGATC~rCAAAGAAGAC 1137 
hAA'i'Gc'~AACCAc;ACAn'rcTnlT~CAA~A~cTnAGAA~Ann'An'Gn'rCAACA 1197 
ATAAA'~ATAtTAA'lTCAAAAAAAAAAAAAAAAAAAAA 1251 
The cDNA clones for cathepsin S were derived from 
reverse transcribed bovine spleen poly(A+) RNA after 
PCR amplification. From the amino acid sequences of
16 bovine cathepsin S tryptic peptides, four peptides 
were chosen and the corresponding oligonucletide 
primers were synthesized, The primers used to isolate 
cathepsin S clones are described in Fig. 1. The initial 
cathepsin S cDNA clone was isolated with primer com- 
bination 1 and 2. The sequence of primer 1 encodes a 
conserved peptide near the amino terminus of the pa- 
pain enzyme family which contains the active site cys- 
teine and the sequence of primer 2 is antisense code for 
another conserved pepridc near the carboxyl-terminus. 
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0.7 kb Q 
Fig. 3. RNA blot hybridization predicts a single species of bovine 
cathepsin S in the spleen. The estimated size is 1.7 kb, using ethidium 
bromide stained RNAs as mobility markers. 
Two cDNA clones amplified with primers 1 and 2 were 
isolated from independent PCR reactions. The nucleic 
acid sequence of these clones predicts an open reading 
frame which would code for 10 of the analyzed tryptic 
peptides generated from the cathepsin § protein. Three 
additional cathepsin S specific primers and the adapter 
described in Fig. 1 were used to amplify the additional 
cathepsin S cDNAs and resulting clones described in 
Fig. 2. All tryptic peptide sequences determined were 
present in the single open reading frame identified as 
cathepsin S. A stop codon immediately follows the 
nucleotides for the last determined amino acid (Be) in 
cathepsin S-(ZOl-217)-peptide. This shows that mature 
cathepsin S is not processed at its C-terminus and con- 
sists of 217 amino acid residues corresponding to a 
molecular weight of 23.7 kDa. This molecular weight is 
in excellent agreement with the apparent molecular 
weight 24 kDa determined by SDS-PAGE. 
Only a single band of 1.7 kb can be detected after blot 
hybridization to bovine spleen poly(A +) RNA in- 
dicating that the cDNA clones were probably derived 
from a single molecular species of RNA (Fig. 3). The 
cDNA amplified with primer combination 4 and 2 
results from unpredicted priming of primer 4 at nucleo- 
tides 205-228. One clone predicts a proline (CCT) at 
amino acid 143 whereas the other two independent 
clones covering the same region predict a serine (TCT). 
Another single nucleotide discrepancy occurred at 
nucleotide 798. These differences may reflect the fideli- 
ty of replication of the TAQ polymerase. 
Bovine cathepsin S primary structure shows 56% 
identity to cathepsin L [14], 47% to cathepsin H [15], 
31% to cathepsin B 1161 and 41% to papain [17] (Fig. 
4), Overall there are 38 identities (18%) shared by all 
five enzymes. Cys-25 and His-164 of bovinecathepsin S 
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SEQUENCE NUMBCB 
1 
s raDwR6.m. ..Qa6GscilaT,:BRvuI&&R 
II APAS~WAERE.YVTPVkN. 
QVXLXTG.~ 
YP@SvIwhRR Gm-JSPVXN. 
..Q3QCGxl~ AS!SATGALizG QuPqo.P.% 
:.qain IPBYVIJKXQK Q.AVIPVKN 
..@3ACG3Cff'Pa3TTGALESAXAXA56.XM 
. ..QGSCQSw AlP'bAMITIXG I~KIWO.WL 
B LPAS6"DAICZQWPOcPTIkeI 3BQ3SC(IBCI(AbAVEAISDRI'CIKTNAw 
46 
S 
L 
.VSLSAQNLV DCSTAXYGNK GCKd 
94 
FQYIIDSWor DSEASY9YRA 
K 
.ISLSEQN$V DCSGPQ.GNE wpU.iDY+ FQYVQBNGQL DSEESYPYRh 
.LSLAE.WLV BCAQD.BNNY GCQ$!+PSQA WYILYRXGJI UGEDTYPYQG 
Papain N.QYSPQiZLL DCDXRSY... GkNwYPWSA LQLVAQY.61 RYMTPYYR5 
@I SVEVSAmLL TCCGSMCGD. bQ+Gwaaa wNmmR.XGL VSGGL..Ym 
95 119 
S MDGKC0.Y.. .._....... .D-mWAaAT~ SILYIELPP'C.. . . . . . . . 
L TEE5CK.Y ............ .NPKYSVAKD TGPVDIPX ............ 
II KDGYCK.P ............ QPGKAIGPVX DVANITIY ............ 
Papain VQRYCR ............. . RERGPYAAXT DGVXQVQPY. ......... 
6 R"G.bKPYSI PPCEKQVNGS APPCTGEGDT BRCSKICKPG YSPTYKQDK,, 
120 1.58 
S . . v . . . . . . . S&W-W WRGPVSVGID ASKSSF"PLYK TQ'dYYDP.SC 
L . . . . . . . . . . Q&-VA TvobIEWZSD ~,tESPbpyII SGIYPRPDC3 
K . . . . . . . . . . DE-VA LYNPVSPAPE VTQ.DFMMYK 'SEIIYSSTSCH 
Pepsin . . . . . . . . . . NQGALLYSIA NQ.PVSWM AAGRO~QLYR GGIwO9..C 
D YGYDSYSV6N SERDIMAEIY FNGtiVEGAPS VY..BDPLL&Z SoWpmR.. 
159 202 
S ..TQHvDMGV LWGYGKLDG XD . . ..XWLV RNSWGLKPGD QJJXZXXMNS 
L . .BEDMDKGV LVVGYGFSST ESDNRKYWLV KRSWGEEWGM GGYVfGUKDK 
n KTPDKVNKAV LAVBYGOBKMG IP . . ..YWFI RX3WGPOWGH NGYPLPERG. 
eepain ..GNXVDBAV AAWYEDG.. . . . . ..YILI RX~WGTBWGB: NQYIRIIC4GT 
B .GEMMGGIlbI RILGWGVKNG TP....tWLV AN$mWGD NGFaKILXGQ 
205 2L7 
s G3K...CGIANY@3YPES.. , 
L RNU...CGIA SAASYPTV.. , 
3 mM...CQLA ACAStPIPLv , 
Papain GSBYGVCGLY TSSFYPVIM. 
8 .DB..,CGIE SKVVAGIPRT I; 
Fig. 4. Alignment of the amino acid sequences of bovine cathepsin S, 
human cathepsins L (141, H [ISJ, and B [16J, and papain [17J. The 
gaps have been introduced to achieve maximal homology. Shaded 
amino acids arc ideutical in all five enzymes. 
correspond to the papain active site [17]. Amino acids 
directly flanking Cys-25 are highly conserved whereas 
those flanking His-164 are not identical but have similar 
side chains. The greater similarity of cathepsin S to 
cathepsin L is in keeping with the similar enzymatic prs- 
perties of the two enzymes [2,3,18]. 
Cathepsins S and papain are single chain enzymes 
whereas cathepsins H, L and B are two chain enzymes. 
Cathepsin B is cleaved close to the N-terminus of the 
polypeptide and is stable to cleavage between residues 
164 and 186 like cathepsin S and papain, Fig. 5 shows 
the predicted secondary structure of cathepsins and 
average flexibility parameters in the region where 
cathepsins H and L are cleaved to produce the heavy 
and light chains, respectively. This region is not con- 
served in cysteine proteinases but is flanked by two con- 
served regions which correspond to cathepsin S 
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Secondary 8lruclure Flexi- Refer- 
bilitv ence 
consensus 
human L 
mowe L 
rat L 
human H 
rat H 
bovine S 
human S 
human I3 
rat B 
mow* 8 
bovine 5 
papain 
276 
276 
276 
281 
166 
164 
164 
278 
197 
278 
19.9 
292 
t-BBBBBB-tt-TkTTTTBBBBBttTT 
~-,sBeese-tt=T~T'TTTBBB~~ttTT 
BBBBBBttt-TJ'-BBBBBBttTT 
BBBBBBttt-TTtBBBBBBttt- 
BBEBBBttttttt-BBBBBtttb 
BBRBBBttttttt-BBBBBttTT 
hhkhhh----tt---BB8ECXtt 
-BBBBR---------BBBBBttB 
-BBBBBBB--tt-BFJBBBBttt- 
-BBBBB----tt---BBBBB??? 
HHWHHWttt-BBBBBttTT 
1.089 
1.071 
1.065 
1.058 
1.058 
1.048 
1.040 
1.043 
1.004 
1.003 
1.043 
Fig. 5. The secondary structure and chain flexibility adjacent to the 
site of cleavage during formation of cathepsins L and H heavy and 
light chains. Upper case and lower case B, T and H indicate strong 
and weak predictions of B sheet, turn and helix, respectively. The 
cleavage sites are shown by the arrows. The consensus sequence for 
this region is shown at the top, where n represents a variable length. 
unconserved sequence ranging in length: 10 amino acids in cathepsin 
L, 6 amino acids in cathepsins S, H and B, and 2 amino acids in pa- 
pain. The secondary structure symbols corresponding to the conserv- 
ed amino acids of the consensus are underlined. The average of the 
flexibility values for the cathepsins in the variable region is shown. 
The value for papain is 0.989. Secondary structure (Chou-Fasman 
[28]) and flexibility (Karplus and Schulz [29]) were calculated by using 
the Peptidestructure program of the Genetics Computer Group, 
Madison, WI. ‘Refers to the position of the conserved H in the en- 
zyme or prepro-enzyme sequence. **This manuscript. “‘B. 
Wiederanders (unpublished results). 
(164-173) and (178-186). Secondary structure calcula- 
tions predict hat the conserved regions tend to form ,B 
sheets. The intervening sequences which are cleaved in 
cathepsins H and L are strongly predicted to form 
reverse turn structures and to display more flexibility 
than in cathepsins S and B which are >ot cleaved in this 
region, A comparison of the means of the flexibility 
values for cathepsins H and L to those of S and B in- 
dicates a statistically significant difference (t-test, 
P = 0.0046). Thus, the absence of a reverse turn and/or 
insufficient chain flexibility may render cathepsin S 
resistant o cleavage between amino acids (173-178). 
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